Original Article

Chargemaster Pricing Variation for Commonly Billed Procedures in Interventional Cardiology

Authors: Richard S. Chaudhary, MD, Amanda Kadesh, MD, Saman Baban, MD, MHS, Aiden Lui, BS, Jeanne Shi, MD, Jai Ahluwalia, BS, Michael White, MD, PhD, Dobie Giles, MD, MS, Timothy R. Petersen, PhD, Adam E. Block, PhD, Craig Basman, MD, Cara L. Grimes, MD, MAS

Abstract

Objectives: A chargemaster is a database of all of the billable items offered by a hospital with their base price listings. A 2018 executive order required all American hospitals to publish their chargemasters to increase price transparency and reduce healthcare expenditures. Chargemaster listings, however, demonstrate marked variability and inconsistency and have not been associated with consumer benefit. The objective of this study was to analyze chargemasters for commonly billed interventional cardiology procedures across five diverse states to explore relationships between price listings and hospital characteristics, ownership, location, and hospital quality.

Methods: Chargemasters were downloaded from hospitals in five states selected to represent the nation’s healthcare diversity. Price listings for five interventional cardiology procedures (percutaneous coronary angiography, coronary angiography, single-vessel angioplasty, single-vessel stent, and percutaneous coronary intervention of acute myocardial infarction) were extracted. Statistical analyses such as the Kruskal-Wallis test were performed to explore relationships between mean chargemaster price listings for each procedure and hospital characteristics, ownership, location, and quality ratings.

Results: The median mean chargemaster price of four of the five interventional cardiology procedures significantly differed across all states. Price listings were significantly higher in urban versus rural areas and in general acute care hospitals and state government-owned facilities. The highest prices were found with the highest hospital quality rating.

Conclusions: Chargemaster price listings for common interventional cardiology procedures varied significantly across these five states. Urban and metropolitan hospital location, hospital type, and hospital ownership could be factors driving increased chargemaster procedure prices. Prices were highest at hospitals with the highest quality rating.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. David K, Stremikis K, Squires D, et al. Mirror, mirror on the wall: how the performance of the U.S. health care system compares internationally. https://www.commonwealthfund.org/sites/default/files/documents/___media_files_publications_fund_report_2014_jun_1755_davis_mirror_mirror_2014.pdf. Published June 16, 2014. Accessed December 22, 2021.
 
2. Nunn R, Parsons J, Shambaugh J. A dozen facts about the economics of the US health-care system. https://www.brookings.edu/articles/a-dozen-facts-about-the-economics-of-the-u-s-health-care-system/. Accessed December 22, 2021. Published March 10, 2020.
 
3. US Department of Health & Human Services. Trump administration announces historic price transparency requirements to increase competition and lower healthcare costs for all Americans: Two regulations advance the Trump administration’s commitment to increasing price transparency. https://public3.pagefreezer.com/browse/HHS.gov/31-12-2020T08:51/https://www.hhs.gov/about/news/2019/11/15/trump-administration-announces-historic-price-transparency-and-lower-healthcare-costs-for-all-americans.html. Published November 15, 2019. Accessed December 22, 2021.
 
4. Keith K. Unpacking the Executive Order on health care price transparency and quality. http://crm.sma.org/index.php?-table=SMACRM&-action=login_prompt&-cursor=0&-skip=0&-limit=30&-mode=list. Published June 25, 2019. Accessed December 22, 2021.
 
5. Reddy S, Daly G, Baban S, et al. Accessibility and usability of hospital chargemasters in New York State. J Gen Intern Med 2022;37:2130-2131.
 
6. Tompkins CP, Altman SH, Eilat E. The precarious pricing system for hospital services. Health Aff 2006;25:45-56.
 
7. Batty M, Ippolito B. Mystery of the chargemaster: examining the role of hospital list prices in what patients actually pay. Health Aff 2017;36:689-696.
 
8. Bai G, Anderson GF. US hospitals are still using chargemaster markups to maximize revenues. Health Aff 2016;35:1658-1664.
 
9. Wan W, Itri J. Charge master: friend or foe? Curr Probl Diagn Radiol 2016; 45:122-127.
 
10. Graver R. Your path to success: expert advice. Cath lab profitability. https://www.hmpgloballearningnetwork.com/site/cathlab/article/cath-lab-profitability. Published August 2017. Accessed December 22, 2021.
 
11. Bresnick J. Cardiovascular disease may incur $1 trillion in costs by 2035. HealthITAnalytics. 2017. Available at: https://healthitanalytics.com/news/cardiovascular-disease-may-incur-1-trillion-in-costs-by-2035. Accessed June 19, 2023.
 
12. BlueCross BlueShield. A study of cost variation for percutaneous coronary interventions (angioplasties) in the U.S. https://www.bcbs.com/the-health-of-america/reports/study-of-cost-variation-percutaneous-coronary-interventions. Published July 16, 2015. Accessed December 22, 2021.
 
13. Radley DC, Collins SR, Baumgartner JC. 2020 scorecard on state health system performance. https://2020scorecard.commonwealthfund.org/. Published 2020. Accessed December 22, 2021.
 
14. Homeland Infrastructure Foundation-Level Data (HIFLD). Hospitals. https://hifld-geoplatform.opendata.arcgis.com/maps/geoplatform::hospitals/about. Published June 30, 2020. Accessed December 22, 2021.
 
15. California Office of Statewide Health Planning and Development: Hospital chargemasters. https://hcai.ca.gov/data-and-reports/cost-transparency/hospital-chargemasters/. Published 2021. Accessed December 22, 2021.
 
16. geoplatform.gov. Making federal geospatial FAIR. https://www.geoplatform.gov/. Accessed December 23, 2021.
 
17. US Department of Agriculture Economic Research Service. Rural-urban continuum codes. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx. Published 2013. Accessed December 22, 2021.
 
18. Centers for Medicare & Medicaid Services. Hospital quality initiative public reporting. Hospital care compare and provider data catalog. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/HospitalCompare. Published 2020. Accessed December 22, 2021.
 
19. Centers for Medicare & Medicaid Services. Comprehensive methodology report (v3.0). https://qualitynet.cms.gov/inpatient/public-reporting/overall-ratings/resources. Published 2020. Accessed December 22, 2021.
 
20. Lu AJ, Chen EM, Vutam E, et al. Price transparency implementation: accessibility of hospital chargemasters and variation in hospital pricing after CMS mandate. Healthc (Amst) 2020;8:100443.
 
21. Beauvais B, Gilson G, Schwab S, et al. Overpriced? are hospital prices associated with the quality of care? Healthcare (Basel) 2020;8:135.